| abstract |
"Piperazine with or substituted by phenyl group and its use as glyt1 inhibitors". The present invention relates to compounds of formula (I) wherein the substituents are described in claim 1. The compounds may be employed in the treatment of glycine uptake inhibitor based diseases such as psychosis, pain, neurodegenerative dysfunction and memory and learning, schizophrenia, dementia and other diseases in which cognitive processes are impaired, such as attention deficit disorder or alzheimer's disease. |